Nanotein & Akron Bio Partner for cGMP production of NanoSpark® STEM-T Soluble T Cell Activator. Read More

News

Nanotein Exhibits at ISCT 2022

Nanotein presents ISCT exhibit

Curtis Hodge, CEO & Co-Founder of Nanotein, along with Zach Imam, Scientist II, presented Nanotein’s first exhibit at the ISCT 2022 conference in San Francisco, California. Throughout the conference from May 4th to 6th, they received lots of interest from potential beta-testers, collaborators, partners, and future customers!